Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
PharmaCyte Biotech, Inc. is a biotechnology company, which is focused on developing cellular therapies for cancer based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC) will be developed. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used as a means to produce various biologically active molecules. The technology is intended to result in the formation of pinhead-sized cellulose-based porous capsules in which genetically modified live human cells can be encapsulated and maintained. In a laboratory setting, this proprietary live cell encapsulation technology has been shown to create a micro-environment in which encapsulated cells survive and flourish.
Find out what a historical investment in PharmaCyte Biotech Inc would be worth today using our PMCB stock calculator.
Buying PMCB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PharmaCyte Biotech Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PMCB
What is the ticker symbol of PharmaCyte Biotech Inc?
The ticker symbol for PharmaCyte Biotech Inc is PMCB.
How much is one share of PMCB?
One share of PMCB is valued at $4.56 as of 20 November 2026.
What is the market capitalisation of PharmaCyte Biotech Inc PMCB?
As of 20 November 2026 PharmaCyte Biotech Inc has a market cap of $3.04M.
What is the 52-week high for PharmaCyte Biotech Inc stock?
The PharmaCyte Biotech Inc 52-week high stock price is $28.69.
What is the 52-week low for PharmaCyte Biotech Inc stock?
The PharmaCyte Biotech Inc 52-week low stock price is $4.56.
Can I buy PMCB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PMCB shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PMCB on Stake
Buy PMCB from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PMCB from only US$10 with fractional shares